Case report: Successful treatment with spesolimab of acrodermatitis continua of Hallopeau in an older patient without IL36RN mutations
BackgroundAcrodermatitis continua of Hallopeau (ACH) is a rare, sterile pustular psoriasis variant refractory to many conventional treatments. The eruption typically occurs after local trauma or infection; other etiologies include neural, inflammatory, and genetic causes. Herein we reported a single...
Saved in:
Main Authors: | Jianfeng Zheng, Yangfeng Ding, Yuling Shi, Xuemei Yi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1440102/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Single-centre Retrospective Study
by: Yoshiki Okada, et al.
Published: (2025-02-01) -
Crusted Scabies in a Patient being Treated with Spesolimab for Generalized Pustular Psoriasis
by: Hanna Schratter, et al.
Published: (2025-02-01) -
Case report: A rollercoaster journey of pemphigus vegetans
by: Xiaoyuan Hou, et al.
Published: (2025-01-01) -
Successful treatment of severe acrodermatitis continua of hallopeau with Bimekizumab: A case report
by: Lily Xu, et al.
Published: (2025-01-01) -
Real-Life Analysis of Therapeutic Management and Its Correlation With the Dermatology Life Quality Index Score in 108 Patients With Pustular Psoriasis: An Italian Monocenter Study
by: Dario Buononato, et al.
Published: (2025-01-01)